ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

251
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Refresh
bullishSoftbank Corp
01 Dec 2018 17:34

ECM Weekly (1 December 2018) - Softbank Corp, Tencent Music, Cansino, Wuxi Apptec, Fosun Tourism

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
bearishWuXi AppTec
29 Nov 2018 08:23

WuXi AppTec IPO Valuation: Not Much Money Left on the Table

WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....

Logo
596 Views
Share
bullishWuXi AppTec
28 Nov 2018 11:42

WuXi Apptec (药明康德) IPO:Upside at Middle and Low End

Wuxi Apptec launched book building today with a price range of HKD 64.10 to HKD 71.50, planning to raise USD 954 million to USD 1,064 million. In...

Logo
735 Views
Share
bearishWuXi AppTec
28 Nov 2018 05:57

WuXi AppTech IPO Update: Figuring Out the Right AH Premium

WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....

Logo
717 Views
Share
bearishWuXi AppTec
26 Nov 2018 05:52

Last Week in GER Research: WuXi App, Don Quijote, Koolearn, Asiainfo and China's Bike Sharing Bubble

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we update on IPO WuXi AppTec Co....

Logo
433 Views
Share
x